What Is REBYOTA™?
Learn about REBYOTA and how it helps prevent the recurrence of C. diff infection.
I just knew that if I had C. diff again, I wasn’t going to survive. But my C. diff didn’t come back after I had my treatment.
Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.
For more information, please talk to your doctor and see full Prescribing Information. Freda was compensated for her time. Individual results may vary.
Most common side effects may include stomach pain (8.9%), diarrhea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).1
In clinical studies, there were no serious adverse events related to REBYOTA.1
aThe study was conducted in approximately 300 adult patients with recurrent C. diff infection for up to 8 weeks to find out how well REBYOTA
prevented recurrent C. diff infection. Patients in this study first completed treatment with antibiotics.1,2
bSuccess rate indicates no other recurrence of C. diff infection at 8 weeks.2
Receive additional information and resources to help you through your C. diff infection journey.
REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals
18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.
You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.
Please click to see the full Prescribing Information
The link you have selected will direct you to a site or resource outside of our website.